Madison Avenue International LP 13D/13G Filings for Sage Therapeutics, Inc. (SAGE)

Madison Avenue International LP 13D and 13G filings for Sage Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-01
5:35 pm
Purchase
2025-03-25 13G Sage Therapeutics, Inc.
SAGE
Madison Avenue International LP 4,920,763
8.000%
4,920,763increase
(New Position)
Filing